|
Katrijn Boon, PhD, is a postdoctoral researcher in the lab of Prof. Pilar Martinez-Martinez, where she investigates the role of CERT (Ceramide Transfer Protein) in Alzheimer’s disease using both in-vitro as in-vivo assays.
Her scientific journey began with a master’s degree in Biochemistry and Biotechnology at KU Leuven (2014–2019), where her dissertation explored neurodegenerative research using yeast-based models of Alzheimer’s and Parkinson’s diseases. This experience sparked her interest in the molecular mechanisms behind these conditions and motivated her to pursue a PhD in biomedical sciences. In May 2024, she completed her PhD at the Rega Institute, KU Leuven, where her research focused on G-protein-coupled receptors (GPCRs) and their cellular interactions in cancer and anti-inflammatory diseases. She specialized in cell-based assays and advanced protein-protein interaction (PPI) techniques, such as Bioluminescence Resonance Energy Transfer (BRET), which provided her with a thorough understanding of cellular processes in health and disease. Today, as a postdoctoral researcher, she is excited to apply her previous experience and expertise in cellular biology to investigate CERT’s role in Alzheimer’s disease. Her research delves into the molecular pathways of neurodegeneration, leading to the ultimate goal of uncovering new insights paving the way for novel treatments. Linkedin: https://www.linkedin.com/in/katrijn-boon9a8091252/?originalSubdomain=be |
